Management of Cough in COPD Exacerbations

Introduction to COPD Exacerbation Management

• The American Academy of Family Physicians recommends focusing on treating the underlying exacerbation rather than suppressing the cough reflex during COPD exacerbations 1, 2, 3
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines emphasize bronchodilation and anti-inflammatory therapy without recommending antitussive agents 4

Pharmacological Management

• Short-acting bronchodilators, such as beta-agonists and anticholinergics, are the cornerstone of acute symptom management in COPD exacerbations 2, 4, 5
• Systemic corticosteroids reduce inflammation and improve clinical outcomes in COPD exacerbations 3, 4
• Antibiotics are recommended when indicated, such as in the presence of increased dyspnea, increased sputum volume, and purulent sputum 1, 6

Addressing Cough

• Encouraging sputum clearance through coughing is explicitly recommended in COPD exacerbations 7
• Bronchodilator therapy can indirectly reduce cough by improving airflow obstruction 5, 8
• Ipratropium bromide has been shown to reduce cough frequency and severity in chronic bronchitis patients 5, 8

Critical Safety Considerations

• Benzonatate is a cough suppressant that works by anesthetizing stretch receptors in the respiratory tract, and its use may precipitate respiratory failure in patients with COPD exacerbations 4, 6
• Patients with COPD exacerbations may have borderline gas exchange, making them vulnerable to further respiratory compromise 7

Common Pitfalls to Avoid

• Do not reflexively prescribe cough suppressants for any cough in COPD patients—distinguish between stable disease and acute exacerbations 5
• Do not mistake productive cough for a symptom requiring suppression—it is a necessary clearance mechanism during exacerbations 7
• Reassess patients within 48 hours if managing outpatient to ensure the patient is improving with standard therapy 7